Progress in cutting hospital prescribing of broad-spectrum antibiotics set back by pandemic

  15 May 2021

Efforts to reduce hospital prescribing of broad-spectrum antibiotics have been hindered by the COVID-19 pandemic, NHS England’s antimicrobial resistance (AMR) lead has said.

Kieran Hand, the national pharmacy and prescribing clinical lead for AMR at NHS England and Improvement, said that between 2017 and 2019, prescribing per hospital admission of certain broader-spectrum antibiotics fell by 5.5%.

However, speaking at the Clinical Pharmacy Congress on 13 May 2021, he said that this trend reversed between 2019 and 2020, when prescribing of these antibiotics increased by 3.6%, owing to increased use during the first and second waves of the pandemic.

Author(s): Julia Robinson
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!